Back to Search
MEGAN ERION, DOCTORAL CANDIDATE
DOCTORAL CANDIDATE
Clinical Psychologist
NPI: 1952634230Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
020205(NY)
Research & Publications (20)
Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
PMID 18041833·J Am Chem Soc·2007
7-preclinical
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
PMID 17878314·Proc Natl Acad Sci U S A·2007
7-preclinical
HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.
PMID 16499280·Curr Opin Investig Drugs·2006
6-review
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
PMID 15911772·Proc Natl Acad Sci U S A·2005
4-observational
Liver-targeted drug delivery using HepDirect prodrugs.
PMID 15340017·J Pharmacol Exp Ther·2005
7-preclinical
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.
PMID 15099098·J Am Chem Soc·2004
7-preclinical
Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.
PMID 19348494·J Med Chem·2009
7-preclinical
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
PMID 19283354·Cancer Chemother Pharmacol·2009
7-preclinical
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.
PMID 19183199·Br J Pharmacol·2009
7-preclinical
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.
PMID 19072834·Hepatology·2009
7-preclinical
Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.
PMID 18975928·J Med Chem·2008
7-preclinical
Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.
PMID 18703645·Drug Metab Dispos·2008
4-observational
Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.
PMID 18570362·J Med Chem·2008
7-preclinical
Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.
PMID 18173234·J Med Chem·2008
7-preclinical
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
PMID 18041834·J Am Chem Soc·2007
7-preclinical
Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.
PMID 17659484·Curr Opin Drug Discov Devel·2007
6-review
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
PMID 17636948·J Med Chem·2007
7-preclinical
Relative binding affinities of fructose-1,6-bisphosphatase inhibitors calculated using a quantum mechanics-based free energy perturbation method.
PMID 17616196·J Am Chem Soc·2007
8-other
Bis[(para-methoxy)benzyl] phosphonate prodrugs with improved stability and enhanced cell penetration.
PMID 17459701·Bioorg Med Chem Lett·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2401 MERCED ST
SAN LEANDRO, CA 94577 - Phone
- (206) 595-9523
Quick Facts
- NPI
- 1952634230
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile